13:11 02/07/2015 Maxim Shines Light on AEterna Zentaris Inc. (USA)'s Phase 3 ZoptEC Clinical ...
Maxim Shines Light on AEterna Zentaris Inc. (USA)'s Phase 3 ZoptEC Clinical ...
Smarter Analyst - 22 hours ago
Maxim Group's healthcare analyst Jason Kolbert came out with a research report on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) following the news that the company has reached its goal of recruiting 500 patients for its pivotal Phase 3 ZoptEC clinical ...
Maxim Group Reaffirms “Buy” Rating for AEterna Zentaris (AEZS) - Dakota Financial News

11:07 02/07/2015 Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AEterna Zentaris Inc.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AEterna Zentaris Inc.
Wall Street Observer - Jul 2, 2015
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) declined -2.14% to end last trading session at $0.275. The company, on June 30, 2015, released that it has reached its goal of recruiting 500 patients for its pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in ...
Investor's Watch List: Ariad, (NASDAQ:ARIA), Teradata (NYSE:TDC), SolarCity ... - Investor Wired

11:07 29/06/2015 Chasing Hot Biotech Stocks - Sorrento Therapeutics Inc (NASDAQ:SRNE ...
Chasing Hot Biotech Stocks - Sorrento Therapeutics Inc (NASDAQ:SRNE ...
Wall Street Observer - Jun 29, 2015
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) declined -2.98% to end last trading session at $0.280. The company, on June 25, 2015, released that it has executed a definitive agreement with Ergomed PLC (“Ergomed”), pursuant to which Ergomed will ...

11:30 25/06/2015 Biotech Stocks in News -AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) , CTI ...
Biotech Stocks in News -AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) , CTI ...
Wall Street Observer - Jun 25, 2015
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)retreated -2.14% to complete last trading session at $0.274. The company, on June 18, 2015, reported that it has received notice from the NASDAQ Listing Qualifications Department (“NASDAQ”) determining that ...
Market Buzz: RXi Pharmaceuticals Corp(NASDAQ:RXII), AEterna Zentaris Inc ... - Market News Call
AEterna Zentaris Inc. Price Target Update - Money Flow Index

19:33 15/06/2015 Maxim Sees Compelling Value In AEterna Zentaris Inc. (AEZS)
Maxim Sees Compelling Value In AEterna Zentaris Inc. (AEZS)
Smarter Analyst - Jun 15, 2015
Maxim Group analyst Jason Kolbert came out with a research report on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after visiting with management in South Carolina and reviewing the company fundamentals.
Company Shares of AEterna Zentaris Inc. Rally 1.18% - News Watch International
Special News Alert: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Speed ... - Market News Call

13:02 26/05/2015 Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA)'s Confirmatory ...
Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA)'s Confirmatory ...
Smarter Analyst - May 26, 2015
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it has received written scientific advice from the European Medicines Agency (“EMA”) regarding the further development plan, including the study design, for the new confirmatory Phase 3 clinical ...
Aeterna Zentaris' Confirmatory Phase 3 Study for Macrilen(TM) in AGHD Meets ... - Stockhouse

21:37 21/05/2015 HC Wainwright Pounds the Table on AEterna Zentaris Inc. (USA)
HC Wainwright Pounds the Table on AEterna Zentaris Inc. (USA)
Smarter Analyst - May 21, 2015
H.C. Wainwright analyst Swayampakula Ramakanth was out pounding the table on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) Thursday, reiterating a Buy rating and price target of $1.25, which represents a potential upside of about 315% from where the ...
Major Falls in Review: Achillion Pharmaceuticals, (NASDAQ:ACHN), AEterna ... - wsnewspublishers
Volume Alert: MannKind Corporation (NASDAQ:MNKD), Gilead Sciences Inc ... - Market News Call

19:09 11/05/2015 AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) a Hold: Canaccord Genuity
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) a Hold: Canaccord Genuity
Markets.co - May 11, 2015
In a research note issued to investors, Neil Maruoka at Canaccord Genuity Reiterated their Hold rating on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS). The analyst placed a $0.70 price target on the stock which indicates a 45.83% upside to the last ...
Oversold Stocks: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), NewLink ... - Wall Street Observer
Canaccord Insights Update: Apple Inc. (AAPL), NVIDIA Corporation, (NVDA ... - Smarter Analyst

0:21 09/05/2015 Canaccord Offers Commentary on AEterna Zentaris Inc. (USA) Following ...
Canaccord Offers Commentary on AEterna Zentaris Inc. (USA) Following ...
Smarter Analyst - May 8, 2015
In a research report released today, Canaccord Genuity analyst Neil Maruoka reiterated a Hold rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $0.70 price target, after the company announced an agreement with EMD Serono that will ...
Aeterna Zentaris and EMD Serono Finalize Promotional Services Agreement for ... - PR Newswire (press release)
Æterna Zentaris (AEZS), EMD Serono Finalize Promotional Services Agreement ... - StreetInsider.com

21:33 19/03/2015 Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 4Q:14 Update
Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 4Q:14 Update
Smarter Analyst - Mar 19, 2015
Maxim Group's healthcare analyst Jason Kolbert came out with a research note on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company reported its fourth-quarter financial results and provided a corporate update.